Magazine Article | February 1, 2019

Why 2018 Was The Year Of Real-World Evidence For Biosimilars

Source: Life Science Leader

By Anna Rose Welch, Director, Cell & Gene Collaborative

In 2018, it became clear to me that the biosimilar industry had taken the need for real-world evidence (RWE) to heart. At a conference in Brazil in August, I was asked to present on the RWE efforts I felt were particularly notable. In doing the research for this presentation, my eyes were opened to the pace at which biosimilar evidence is being released.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: